Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Another beneficial effect of rituximab on refractory and relapsing thrombotic thrombocytopenic purpura — Se Jin Park (2012) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Another beneficial effect of rituximab on refractory and relapsing thrombotic thrombocytopenic purpura
JS
Shared by
Jae Il Shin
Another beneficial effect of rituximab on refractory and relapsing thrombotic thrombocytopenic purpura
Letter
2012
en
Authors
SP
Se Jin Park
JS
Jae Il Shin
Abstract
1 min read
Department of Pediatrics, Ajou University School of Medicine, Ajou University Hospital, Suwon, Korea The Institute of Kidney Disease, Department of Pediatrics, Yonsei University College of Medicine, Severance Children’s Hospital, Seoul, Korea
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2007
Comment on Recurrent Henoch-Schonlein Purpura in Children
Jae Il Shin
,
Ji Hong Kim
,
Jae Seung Lee
Letter
2009
Beneficial effect of intravenous immunoglobulins on systemic capillary leak syndrome in patients with monoclonal gammopathy
Jae Il Shin
,
Jae Seung Lee
Letter
2011
Is there a link between the use of etanercept and Henoch-Schönlein purpura?
Se Jin Park
,
Ji Hong Kim
,
Jae Il Shin
Letter
2013
Another Possible Underlying Mechanism for the Positive Association Between Celiac Disease and Systemic Lupus Erythematosus: The Role of Interleukin 21
Sung Won Park
,
Se Jin Park
,
Jae Il Shin
Letter
2007
Re: The Relationship Between Varicoceles and Obesity
Jae Il Shin
,
Jae Seung Lee
Discussion(0)
No comments yet. Be the first to comment.